{"id":"W2789626795","doi":"10.1016/s1470-2045(18)30143-8","title":"Nilotinib in locally advanced pigmented villonodular synovitis: a multicentre, open-label, single-arm, phase 2 trial","year":2018,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Musculoskeletal synovial abnormalities and treatments","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer","keywords":"Pigmented villonodular synovitis; Medicine; Nilotinib; Clinical endpoint; Internal medicine; Synovitis; Surgery; Progressive disease; Adverse effect; Oncology; Dermatology; Clinical trial; Tyrosine kinase; Rheumatoid arthritis; Disease; Receptor","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005950388,0.0002608843,0.0009344756,0.00007609891,0.0001485622,0.00003662907,0.0004343729,0.0001575376,0.000771196],"category_scores_gemma":[0.0002459384,0.0001754665,0.00006614975,0.0002971985,0.0003242483,0.0001448485,0.0002835222,0.0002868012,0.0002238828],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003893863,"about_ca_system_score_gemma":0.0002056138,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005118783,"about_ca_topic_score_gemma":0.0009670789,"domain_scores_codex":[0.997758,0.0003391956,0.0005469218,0.0004244943,0.0002245511,0.0007068409],"domain_scores_gemma":[0.9987208,0.0002077151,0.000215078,0.0005788234,0.0001135771,0.0001640271],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.556311,0.05049775,0.001697636,0.0002217932,0.0008858105,0.001394731,0.001937839,0.000005603282,0.01531036,0.003344571,0.005720297,0.3626727],"study_design_scores_gemma":[0.7083603,0.05046489,0.0009410854,0.0002570658,0.0002422182,0.0001321989,0.0004078064,0.0004399983,0.001618065,0.0004192897,0.236397,0.0003201195],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9604686,0.0002398844,0.00009190192,0.005175633,0.0009565467,0.003067679,0.0000369486,0.00008414295,0.02987869],"genre_scores_gemma":[0.9911742,0.0001166164,0.001871498,0.004152252,0.001264802,0.0002684521,0.00008202372,0.00003692805,0.001033274],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3623526,"threshold_uncertainty_score":0.8444056,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1019318549396969,"score_gpt":0.4160237556294407,"score_spread":0.3140919006897437,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}